Paul Govern

July 13, 2021

Establishing HIV care in Tennessee

Vanderbilt researchers find that heterosexually active Black males are the least likely to establish HIV care within one month of diagnosis and suggest that targeted interventions focus on this population.

By Paul Govern
July 8, 2021

Delirium and mortality reexamined

A multicenter study of ICU patients found that in the hospital, delirium was associated with a nearly three-fold increase in risk of death the following day, but after discharge there was no association between delirium and mortality.

By Paul Govern
June 21, 2021

Dexmedetomidine and delirium

The sedative dexmedetomidine, when administered during or after heart surgery, is associated with postoperative delirium and adverse outcomes.

By Paul Govern
June 17, 2021

Drug allergy labels in medical records power searches for gene-drug associations

By Paul Govern
June 17, 2021

New neurodegeneration culprit

A young woman with a puzzling neurological illness and novel genetic variant pointed investigators to a role for dysregulated protein kinase D1 in neurodegeneration.

By Paul Govern
June 9, 2021

Award recognizes hands-on contributions to health IT at VUMC

Chetan Aher, MD, assistant professor of Surgery, and Wael Alrifai, MD, assistant professor of Pediatrics and Biomedical Informatics, are the inaugural winners of the Physician Builder Award, sponsored by the Vanderbilt Clinical Informatics Center (VCLIC). They received trophies made from Lego building blocks and gift certificates.

By Paul Govern
June 3, 2021

Predictive model identifies patients for genetic testing

Patients who, perhaps unbeknownst to their health care providers, are in need of genetic testing for rare undiagnosed diseases can be identified en masse based on routine information in electronic health records (EHRs), a research team reported June 3 in the journal Nature Medicine.
By Paul Govern
May 20, 2021

VUMC is pacesetter for national aspirin study

According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.
By Paul Govern
May 3, 2021

Strength in numbers

Voluntary data sharing across a region’s health systems and ambulatory care practices is important for measuring and improving health care quality and safety, Vanderbilt researchers report.
By Paul Govern
April 29, 2021

VUMC team screens high school for SARS-CoV-2 asymptomatic infections

Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.
By Paul Govern
April 23, 2021

Vaccinated patients avoiding hospital stays as pandemic rages on

Vanderbilt University Medical Center (VUMC) is reporting only four persons who have been fully vaccinated against COVID-19 have been diagnosed with COVID during an acute care hospitalization at its facilities over the past four months.
By Paul Govern
April 21, 2021

Study finds dramatic gains in life expectancy for people with HIV in Latin America

A research team from Vanderbilt University Medical Center and institutions across Latin America today reports what looks to be far the largest study to date of life expectancy for people living with HIV infection in low-income or middle-income countries.
By Paul Govern
1 … 17 18 19 20 21 … 52